60 related articles for article (PubMed ID: 4375276)
1. 99mTc-Sn-pyrophosphate complexes, an investigation of its possible structures.
Schümichen C; Rörvik-Schümichen K; Hoffmann G
Nucl Med (Stuttg); 1974 Nov; 13(3):253-7. PubMed ID: 4375276
[No Abstract] [Full Text] [Related]
2. Complexing of reduced technetium and tin(II) by chelating phosphate compounds. II. In vitro stability of pyrophosphate and ethane-1, hydroxy-1, diphosphonate (EHDP) complexes.
Schümichen C; Hohloch M; Hoffmann G
Nuklearmedizin; 1979 May; 18(2):105-9. PubMed ID: 38437
[TBL] [Abstract][Full Text] [Related]
3. Complexing of reduced technetium and tin (II) by chelating phosphate compounds. I. Chemical state of technetium.
Schümichen C; Hohloch H; Schiller A; Pohle W; Hoffmann G
Nuklearmedizin; 1979 May; 18(2):98-104. PubMed ID: 38438
[TBL] [Abstract][Full Text] [Related]
4. Formation and in-vivo-distribution of different 99mTc-Sn-pyrophosphate complexes.
Schümichen C; Roth KH; Hoffmann G
Nucl Med (Stuttg); 1975 Dec; 14(4):323-9. PubMed ID: 2905
[TBL] [Abstract][Full Text] [Related]
5. 99mTc bone scanning agents--II. Adsorption of 99mTc(Sn)pyrophosphate complexes on the mineral phase of bone.
Kroesbergen J; van Steijn AM; Gelsema WJ; de Ligny CL
Int J Nucl Med Biol; 1986; 12(6):411-7. PubMed ID: 3011692
[TBL] [Abstract][Full Text] [Related]
6. A comparison of the bone seeking properties of short-chained 99mTc-Sn-polyphosphates.
Schümichen C; Nakken KF
Nucl Med (Stuttg); 1974 Aug; 13(2):139-43. PubMed ID: 4373697
[No Abstract] [Full Text] [Related]
7. [Concentration of 99mTc-tin-phosphate complexes in soft tissues].
Büll U; von Lieven H; Leisner B
Nucl Med (Stuttg); 1975 Jun; 14(2):91-105. PubMed ID: 170592
[TBL] [Abstract][Full Text] [Related]
8. Kinetics of various 99mTc-Sn-pyrophosphate compounds in the rat. II. In vitro studies.
Schümichen C; Mackenbrock B; Hoffmann G
Nuklearmedizin; 1977 Aug; 16(4):157-62. PubMed ID: 198752
[No Abstract] [Full Text] [Related]
9. Kinetics of various 99mTc-Sn-pyrophosphate compounds in the rat. I. In vivo studies.
Schümichen C; Walden J; Hoffmann G
Nuklearmedizin; 1977 Jul; 16(3):100-3. PubMed ID: 197498
[TBL] [Abstract][Full Text] [Related]
10. [Clinical and experimental evaluation of osteotropic radiopharmaceutical preparations].
Korsunskiĭ VN; Tarasov NF; Koval'chuk ND; Levin VI; Boldyrev PP
Med Radiol (Mosk); 1980 Sep; 25(9):9-13. PubMed ID: 6252408
[No Abstract] [Full Text] [Related]
11. Chemistry of technetium radiopharmaceuticals. I. Exploration of the tissue distribution and oxidation state consequences of technetium (IV) in Tc-Sn-gluconate and Tc-Sn-EHDP using carrier 99Tc.
Hambright P; McRae J; Valk PE; Bearden AJ; Shipley BA
J Nucl Med; 1975 Jun; 16(6):478-82. PubMed ID: 808594
[TBL] [Abstract][Full Text] [Related]
12. Altered 99mTc-pertechnetate distribution in a thyroid scan after 99mTc-Sn pyrophosphate administration.
Montelibano EB; Ford DR; Sayle BA
Clin Nucl Med; 1979 Jul; 4(7):277-82. PubMed ID: 223800
[No Abstract] [Full Text] [Related]
13. [Comparative evaluation of the accumulation of 99mTc-labeled phosphate compounds in the bones].
Atamaniuk NP; Mechev DS
Eksp Onkol; 1985; 7(1):66-7. PubMed ID: 2983974
[TBL] [Abstract][Full Text] [Related]
14. [Effect of preliminary adaptation on 99mTc pyrophosphate accumulation and the development of structural changes in the heart muscle under stress].
Malyshev VV; Treshchuk LI; Kharitonchik EG; Meerson FZ
Biull Eksp Biol Med; 1986 Oct; 102(10):390-2. PubMed ID: 3021255
[TBL] [Abstract][Full Text] [Related]
15. Chemistry of 99mTc tracers. II. In vitro conversion of tagged HEDP and pyrophosphate (bone-seekers) into gluconate (renal agent). Effects of Ca and Fe (ii) on in vivo distribution.
McRae J; Hambright P; Valk P; Bearden AJ
J Nucl Med; 1976 Mar; 17(3):208-11. PubMed ID: 175138
[TBL] [Abstract][Full Text] [Related]
16. [Accumulation of tetracycline, Sn-tetracycline, and 99mTc-Sn-tetracykline in isoprenaline-damaged rat myocardium (author's transl)].
Barnová E; Machán V; Kalincák M; Vilcek S; Barna K; Danis J
Cas Lek Cesk; 1978 May; 117(18):553-6. PubMed ID: 667889
[No Abstract] [Full Text] [Related]
17. Skeletal uptake of pyrophosphate labeled with technetium-95m and technetium-96, as evaluated by autoradiography.
Guillemart A; Besnard JC; Le Pape A; Galy G; Fetissoff F
J Nucl Med; 1978 Aug; 19(8):895-9. PubMed ID: 210266
[TBL] [Abstract][Full Text] [Related]
18. Determination of radiochemical purity and pharmacokinetic parameters of 99mTc-sulphur colloid and 99mTc-tin colloid.
Jovanović V; Konstantinovska D; Milivojević K; Bzenić J
Nuklearmedizin; 1981 Dec; 20(6):279-82. PubMed ID: 7329810
[TBL] [Abstract][Full Text] [Related]
19. Use of Fe(II) or Sn(II) alone for technetium labeling of albumin.
Lin MS; Winchell HS; Shipley BA
J Nucl Med; 1971 May; 12(5):204-11. PubMed ID: 5580834
[No Abstract] [Full Text] [Related]
20. Technetium-99m-Sn-pyrophosphate pharmaco-kinetics and bone image changes in parathyroid disease.
Krishnamurthy GT; Brickman AS; Blahd WH
J Nucl Med; 1977 Mar; 18(3):236-42. PubMed ID: 190364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
